1. Home
  2. JYNT vs SCPH Comparison

JYNT vs SCPH Comparison

Compare JYNT & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JYNT
  • SCPH
  • Stock Information
  • Founded
  • JYNT 2010
  • SCPH 2013
  • Country
  • JYNT United States
  • SCPH United States
  • Employees
  • JYNT N/A
  • SCPH N/A
  • Industry
  • JYNT Multi-Sector Companies
  • SCPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • JYNT Miscellaneous
  • SCPH Health Care
  • Exchange
  • JYNT Nasdaq
  • SCPH Nasdaq
  • Market Cap
  • JYNT 170.3M
  • SCPH 299.0M
  • IPO Year
  • JYNT 2014
  • SCPH 2017
  • Fundamental
  • Price
  • JYNT $10.02
  • SCPH $5.63
  • Analyst Decision
  • JYNT Strong Buy
  • SCPH Buy
  • Analyst Count
  • JYNT 3
  • SCPH 3
  • Target Price
  • JYNT $16.33
  • SCPH $12.00
  • AVG Volume (30 Days)
  • JYNT 82.6K
  • SCPH 2.4M
  • Earning Date
  • JYNT 11-06-2025
  • SCPH 11-12-2025
  • Dividend Yield
  • JYNT N/A
  • SCPH N/A
  • EPS Growth
  • JYNT N/A
  • SCPH N/A
  • EPS
  • JYNT N/A
  • SCPH N/A
  • Revenue
  • JYNT $53,449,713.00
  • SCPH $49,969,000.00
  • Revenue This Year
  • JYNT $8.06
  • SCPH $104.30
  • Revenue Next Year
  • JYNT $11.18
  • SCPH $76.06
  • P/E Ratio
  • JYNT N/A
  • SCPH N/A
  • Revenue Growth
  • JYNT 277.36
  • SCPH 107.79
  • 52 Week Low
  • JYNT $9.58
  • SCPH $1.94
  • 52 Week High
  • JYNT $13.47
  • SCPH $6.28
  • Technical
  • Relative Strength Index (RSI)
  • JYNT 32.25
  • SCPH 63.97
  • Support Level
  • JYNT $9.85
  • SCPH $4.33
  • Resistance Level
  • JYNT $10.74
  • SCPH $5.62
  • Average True Range (ATR)
  • JYNT 0.20
  • SCPH 0.04
  • MACD
  • JYNT -0.05
  • SCPH -0.01
  • Stochastic Oscillator
  • JYNT 18.68
  • SCPH 86.67

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has one operating business segment; The Franchise Operations segment which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the Company's franchise license, which represents symbolic intellectual property.

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.

Share on Social Networks: